| Schedule of Segment Reporting Information, by Segment |
The Company also has certain small cancer related legacy investments and an investment in note receivable from a non-affiliated party that is included in the Corporate and Eliminations section below. |
| Cannabis and Medical Marijuana Segment
| | Legacy Investment
| | Corporate and Eliminations
| | Consolidated
|
| Three months ended June 30, 2015
|
| | | | | | | |
| Net sales
| $
| 30,308
| $
| 598,078
| $
| -
| $
| 628,386
|
| Income (loss) from operations
|
| (7,155)
| | 18,588
| | (205,554)
| | (194,121)
|
| Interest expense
|
| 338
| | 5,004
| | (1,472)
| | 3,870
|
| Depreciation and amortization
|
| 444
| | 6,810
| | 684
| | 7,938
|
|
|
|
|
|
|
|
|
|
|
| Three months ended June 30, 2014
|
| | | | | | | |
| Net sales
| $
| 950
| $
| 508,155
| $
| -
| $
| 509,105
|
| Income (loss) from operations
|
| (12,150)
| | 46,247
| | (349,885)
| | (315,788)
|
| Interest expense
|
| -
| | 7,523
| | 3
| | 7,526
|
| Depreciation and amortization
|
| -
| | 6,091
| | (2,101)
| | 3,990
|
|
|
|
|
|
|
|
|
|
|
| Six months ended June 30, 2015
|
| | | | | | | |
| Net sales
| $
| 30,308
| $
| 1,171,928
| $
| -
| $
| 1,202,236
|
| Income (loss) from operations
|
| (7,155)
| | 80,586
| | (460,868)
| | (387,437)
|
| Interest expense
|
| 338
| | 9,778
| | (2,057)
| | 8,059
|
| Depreciation and amortization
|
| 444
| | 13,620
| | 1,367
| | 15,431
|
|
|
|
|
|
|
|
|
|
|
| Six months ended June 30, 2014
|
| | | | | | | |
| Net sales
| $
| 950
| $
| 998,963
| $
| -
| $
| 999,913
|
| Income (loss) from operations
|
| (33,701)
| | 114,282
| | (491,530)
| | (410,949)
|
| Interest expense
|
| -
| | 11,617
| | 399
| | 12,016
|
| Depreciation and amortization
|
| -
| | 12,182
| | 1,268
| | 13,450
|
|
|
|
|
|
|
|
|
|
|
| Total assets:
|
|
|
|
|
|
|
|
|
| June 30, 2015
| $
| 2,267,542
| $
| 1,097,137
| $
| 1,667,820
| $
| 5,032,499
|
| June 30, 2014
|
| 1,606,043
|
| 1,122,564
|
| 1,783,787
|
| 4,512,394
|
|